UPSC is more aggressive than conventional endometrial cancer because UPSC presents with advanced disease, similar to epithelial ovarian cancer. There are several biomarkers for UPSC, which indicate that the pathogenesis of this condition is different than epithelial ovarian and conventional......
Background: Ovarian cancer is the disease with worst prognosis in oncogynecology. Early detection is difficult and late diagnosis is the most common. Patients and methods: For a 25-year period (1982-2006) 2016 patients with ovarian cancer were treated in our clinic. Results: 85 patients were ...
1.Griffiths CT. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr. 1975;42:101–4.PubMed 2.Meigs J. Tumors of the female pelvic organs. New York: Macmillan; 1934. 3.Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Surv...
Approximately 20% of women with advanced-stage ovarian cancer survive beyond 12 years after treatment and are effectively cured. Initial therapy for ovarian cancer comprises surgery and chemotherapy, and is given with the goal of eradicating as many cancer cells as possible. Indeed, the three phases...
Strategies to prevent the emergence of drug resistance will increase the effectiveness of chemotherapy treatment and prolong survival of women with ovarian... X Yang,J Shen,Y Gao,... - 《International Journal of Cancer》 被引量: 21发表: 2015年 Fertility-sparing surgery in ovarian cancer extended...
Ovarian preservation and staging in reproductive-age endometrial cancer patients may be possible in young women with early stage low grade endometrial cancer but BSO should be strongly considered as part of the surgical treatment.doi... CE Richter,B Qian,M Martel,... - 《Gynecologic Oncology》 ...
In about 75% of people who are diagnosed with ovarian cancer, it is already in advanced stages (III or IV). That makes it a serious condition that needs attention right away. With treatment, it can be controlled in many people, sometimes for a number of years. If the cancer comes back...
(95% CI: 0.31-0.47) less likely to receive surgery (pConclusion: While racial/ethnic disparity in ovarian cancer diagnosis and treatment is not driven by contextual-level factors examined in this study, observed geographic variation in surgery treatment warrants further attention in disparities ...
ovarian cancer: 1) referral to an expert center, with a rate of optimal primary cytoreduction of 75% and utilization of combined intraperitoneal and intravenous adjuvant chemotherapy, and 2) referral to a less experienced center, with a rate of optimal primary cytoreduction of 25% and adjuvant ...
Jennifer Sudimack B.A,Robert J Lee PhD - 《Adv Drug Deliv Rev》 被引量: 1783发表: 2002年 A Review of Vinorelbine in the Treatment of Breast Cancer - ScienceDirect As combinations and sequences of anthracyclines and taxanes increasingly become standard adjuvant treatment for early breast cancer...